Ardelyx (ARDX)
(Delayed Data from NSDQ)
$7.41 USD
+0.91 (14.00%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $7.40 -0.01 (-0.13%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Ardelyx, Inc. [ARDX]
Reports for Purchase
Showing records 1 - 20 ( 174 total )
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Surprise Departure of Chief Commercial Officer Rodriguez Announced
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
It''s Just A Bill, Sitting On Capitol Hill. But, Kidney PATIENT Act Marked Up
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
4Q Recap; IBSRELA Begins March to $1B U.S. Net Sales By 2033
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Biotechnology- Survey Says... Latest Nephrology Survey Sheds Light On Prescribing Trends
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Ibsrela Continues to Perform, As Xphozah Starting to Move; 4Q23 Preannouncement
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
ScriptWatch 2023: Ibsrela, Xphozah Prescription Trends
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
ScriptWatch 2023: Ibsrela, Xphozah Prescription Trends
Provider: Wedbush Securities Inc.
Analyst: CHICO L